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In the context of the current COVID-19 pandemic, congested 
public health facilities pose a health risk to patients with chronic 
conditions such as non-communicable diseases (NCDs), HIV/AIDS 
and tuberculosis (TB). Recent medical research articles and reports 
indicate that patients with chronic conditions have relatively high 
mortality when infected by the severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2).[1-3] During the various alert levels of 
the COVID-19 lockdown, some chronic patients did not risk going 
to clinics for collection of their usual medications, and adherence 
levels dropped substantially.[4] In addition, transport options were 
limited, and up to 11% of patients on chronic medication in cities, 
and 25% from informal settlements, struggled to access care.[5]
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Background. Congestion at health facilities poses the risk of extensive spread of the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) to patients at high risk for severe illness and death due to this infection. During the lockdown to control the spread of the virus, 
many patients with chronic conditions are not visiting health facilities and not collecting their chronic medication. To improve adherence to 
medication, home delivery of medication was instituted for patients with chronic diseases who had been receiving care at the Skinner Street 
Clinic in Tshwane.
Objective. To support patients with chronic diseases who were unable to collect their medication, by remotely consulting (telehealth) and 
delivering their medication during the lockdown due to the COVID-19 pandemic.
Methods. Patients were identified for potential home delivery of medication from the clinic appointment book. Their files were retrieved, and 
they were telephoned and offered the option of receiving medication through home delivery instead of attending a health facility. For those 
who qualified and accepted home delivery, files were sent to the clinic pharmacy. Medication parcels were prepared and sent to ward-based 
outreach teams to deliver to patients. Relevant information was captured on the Qualtrics platform.
Results. A total of 1 727 files were evaluated. Of these patients, 60% were on treatment for HIV infection, and 19% for hypertension. A total 
of 32% (n=547) were eligible for home delivery of medication, but only 25% of the 1727 patients accepted the home delivery of medication. 
Almost 25% could not be contacted. Compared with those with non-communicable diseases (NCDs) or a combination of HIV and one or more 
NCDs, a higher proportion of HIV-positive patients with no other diagnosis chose not to have their medication delivered at home. Patients 
using the service expressed their appreciation and requested that it be extended to others. 
Conclusion. Home delivery of medication has significant advantages for patients. It can ensure that patients continue to adhere to their chronic 
medication in the midst of the COVID-19 epidemic, without increasing their risk of contracting the virus. Expanding the home delivery of 
medication to more facilities while aligning it with the Centralised Chronic Medicine Dispensing and Distribution programme has the potential 
to alleviate the congestion and workload of primary care facilities while these are under severe pressure owing to the COVID-19 pandemic.
South Afr J Pub Health 2020;4(2):50-55. https://doi.org/10.7196/SHS.2020.v4.i2.124
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Tshwane District in Gauteng Province has a population of 3 275 152 
people, 80% of whom rely on public healthcare services, which are 
offered through 76 primary healthcare (PHC) clinics and community 
health centres (CHCs) situated in the district.[6] Tshwane District 
Hospital has been turned into a COVID-19 hospital, and as a result, 
the Skinner Street PHC clinic situated on the same premises has 
been closed. In 2019/2020, the PHC headcount for the clinic was 
58 147. The clinic serves largely the Tshwane inner city population 
living in high-density housing.[7] Services from the clinic were 
moved to neighbouring PHC facilities such as the FF Ribeiro and 
Folang clinics in subdistrict 3 of the Tshwane Health District.
The Tshwane Health District and City of Tshwane (local 
government), in partnership with the University of Pretoria, have 
been working with the Bill and Melinda Gates Foundation on a 
project to implement home delivery of medication, similar to Project 
Last Mile Delivery and Operation Phuthuma, since April 2020, and 
realised its appropriateness to address the current situation faced by 
the Gauteng Department of Health as a result of the lockdown.
Tshwane Health District already uses a service called Centralised 
Chronic Medicine Dispensing and Distribution (CCMDD), which 
pre-packages medication and allows patients to collect their 
medication at convenient pick-up sites. However, during the 
lockdown, some of those sites were closed. Some of the CCMDD 
pick-up points are within PHC clinics – patients can skip the 
queue and collect their medication (called Fastlane pick-ups) at 
the clinic pharmacy. Many patients were unable to collect chronic 
medication from both the internal (Fastlane) and external CCMDD 
pick-ups, as well as from the usual PHC clinic pharmacy services 
during the lockdown. Therefore, patients enrolled for the home 
delivery pilot project were both CCMDD and non-CCMDD users.
The purpose of the current project is to improve access to chronic 
medications through home delivery, while also decongesting 
medical facilities. It provides optional alternative access to patients 
who miss follow-up consultations or medication collection visits. 
The home delivery also includes a health promotion and prevention 
check, including screening for TB and COVID-19. By enrolling in this 
project, patients do not need to attend health facilities as regularly, 
thereby reducing their risk of exposure to COVID-19.
The project is therefore designed to support patients with 
chronic diseases who are unable to collect their medication during 
the lockdown owing to the COVID-19 pandemic, by remote 
consulting (telehealth) and delivering medication.
Methods
The project used action research methodology to address a service 
delivery problem, using a collaborative approach among the 
partners mentioned above. Chronic patients who attended Skinner 
Street Clinic were included in the study. Excluded were patients due 
for special investigations (e.g. follow-up blood tests) or who needed 
to be physically examined in a face-to-face consultation. In addition, 
patients residing outside the delivery area, and those who declined 
home delivery of medication, were also excluded.
Prior to the rollout of the project, the team worked on setting 
up the necessary systems to allow medications to be transported 
and delivered to patients’ homes. These included creating standard 
operating procedures (SOPs) for telephone calls to patients to assess 
clinical appropriateness and willingness, packaging of medication 
and use of Uber transport to collect medication from the clinic 
pharmacy and take it to community health workers (CHWs) within 
communities. The SOPs also included measures to safeguard 
medication from being lost or stolen, and ways to protect drivers 
and CHWs from COVID-19. Fig. 1 shows the steps undertaken from 
enrolment through to final delivery.
Fig. 2 shows the overarching steps described in Fig. 1 in graphic 
format, including the potential reach of the project (1 800 CHWs in 
the district).
The files of those patients who could not be contacted initially 
were marked as such, and when they attended a neighbouring 
clinic, their phone numbers were verified and they were offered the 
option to leave the queue, return home and have their medication 
delivered to them the next day.
Ethical approval
The study was granted ethical clearance from the Research Ethics 
Committee of the Faculty of Health Sciences, University of Pretoria 
(ref. no. 102/2011).
Results
The project is in its pilot phase, and below we outline the results 
descriptively to showcase its reach and the potential impact if it 
went to scale.
Table 1 describes the 1 727 files that were evaluated for 
inclusion in the project. Within the files evaluated, 357 patients 
had more than 1 diagnosis, 302 had 2 diagnoses, 48 had 3 and 
7 had 4 diagnoses. Therefore, there were 2 146 instances of medical 
conditions identified within the 1 727 files.
Of the 1 727 patients: 
• almost one-third (547 patients, 32%) were immediately suitable 
for home delivery
• 757 (44%) required further investigation or in-person check-up 
and were not suitable for home delivery
• 379 (22%) could not be reached via telephone (voicemail or no 
answer)
• 44 (3%) did not have a correct contact number.
Table 1. Conditions in files evaluated (N=2 146 conditions in 
1 727 files)
Conditions Patients, n (%)*
HIV 1 284 (74)
Hypertension 418 (24)
Mental health-associated conditions 105 (6)
Diabetes mellitus 98 (6)
Dyslipidaemia 61 (4)




Other 51 (3) 
*Total >100% because 357 patients had >1 condition.
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Of the 547 who qualified for home deliveries, 432 (79%) accepted 
home deliveries, and 115 (21%) of the patients did not (Fig. 3).
The 432 (25% of the total 1 727) patients who qualified for 
and agreed to receive home deliveries had the conditions listed 
in Table 2. Of these 432 patients, 102 had more than 1 diagnosis, 
84 had 2 diagnoses, 14 had 3 diagnoses and 4 had 4 diagnoses.
Four patients included in the project also needed to be referred 
for further management at a health facility, and 54 (13%) enrolled 
Identify patients eligible for 
home delivery of medication 
from appointment list 
(list includes upcoming 
and missed appointments)
Administrative sta call patients 
with active repeatable scripts 
and oer home delivery; these 
patients uploaded onto digital 
system (Qualtrics)
Clinicians audit remaining les 
and where appropriate, conduct 
telephonic consultations to 
determine whether chronic 
medication can be safely 
continued/adjusted
Those eligible (CCMDD and 
non-CCMDD) oered home 
delivery option
Eligible patients oered 
enrolment to CCMDD 
telephonically for subsequent 
medication supply
Files of those who accept home 
delivery sent to pharmacy. 
Lists of these patients sorted 
according to geographical 
location (WBOT areas)
Pharmacy team pre-packs 
medication (pre-dispensing)
Medication parcels packed 
in boxes according to 
WBOT area
WBOT co-ordination ocer or 
Uber driver collects medication 
from pharmacy and delivers 
it to WBOT
WBOT team leader facilitates 
home delivery by CHWs
Fig. 1. Project steps. (CCMDD = Centralised Chronic Medicine Dispensing and Distribution system; WBOT = ward-based outreach team; CHW = community 
health worker).
NGO driver
No change to 
packing and labelling
MSD deliver 
as per normal Print sticker 
with veried 
addresses 
place on parcel 
below PMP label




inform patients of 
pending delivery 
and print patient 





Collector signs o 












1 800 CHWs 
with potential 
to deliver 




Volunteer Clinic driver 
(GG)
Fig. 2. Home delivery project. (MSD = medicines supply depot; NGO = non-governmental organisation, GG = government garage vehicle; PMP = patient 
medicine parcel; WBOT = ward-based outreach team; CHW = community health worker.)
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in the CCMDD programme. Ten (2%) of the 432 were already 
enrolled.
Table 3 shows the reasons that 757 patients (44%) did not 
qualify for home delivery.
Fig. 4 shows the medical conditions of those who chose to 
opt in v. those who refused the service. The figure shows that 
those with HIV alone were the most likely to refuse the service 
(n=85). This could be due to stigma associated with HIV in the 
community.
Qualitatively, the project received positive feedback, which was 
collected via the Qualtrics platform at the point of delivery:
‘Highly appreciated service, I am so happy, they look after our 
health.’
‘I am very happy with what health department is doing for us, 
they are taking care of us. I was worried how I was going to get 
to clinic, thanks a lot to the staff members.’ 
‘Patient very happy with treatment home delivery system, 
requests that we should also deliver medication for his wife.’
‘I was very scared of going out because of COVID-19, I am very happy.’
The feedback showed not only acceptance of the new patient-
centric option, but those who were enrolled were eager to get 
other family members enrolled too.
The project used several mechanisms to deliver medication 
(Fig. 2). The Uber option was mainly used for those patients who 
lived further away from the clinic. On 21 May the first Uber delivery 
was completed successfully to the homebased care office in central 
Tshwane. The next day, delivery expanded to Mamelodi. Five (2%) 
of the 432 deliveries failed initially due to the patients not being 
at the delivery address. These were successfully delivered on the 
second attempt after rearranging the time or location of delivery 
telephonically with the patients.
Discussion
This pilot serves as encouragement, and provides data, for decisions 
around whether to expand this community-oriented primary care- 
and telehealth-related intervention to more facilities and districts.
The Western Cape Department of Health, in partnership with 
Aviro, uses WhatsApp and unstructured supplementary service 
data (USSD) to enable patients to provide their latest, most accurate 
contact details.[8] Implementing such a system in Gauteng would 
enhance cost-efficiency, particularly if patients also indicate, through 
such system, their willingness or otherwise to receive medication by 
delivery at home. Clinicians would then waste less time evaluating 
files and making phone calls to patients who do not answer the call 
or do not agree to receive medication by home delivery.
Patients on antiretroviral (ARV) medication without an additional 
diagnosis were less likely to accept home delivery of medication 
than those on treatment for NCDs, or for a NCD as well as HIV. This 
may be due to concerns that their HIV diagnosis could be revealed 
Table 2. Conditions of patients included in project (N=559 
conditions in 432 patients)
Conditions Patients, n (%)*
HIV 281 (65)
Hypertension 148 (34)
Diabetes mellitus 27 (6)






*Total >100% because 102 patients had >1 condition.
Table 3. Reasons for exclusion from project
Reason for exclusion Patients, n (%)
Referral for face-to-face consultation 281 (37)
Due for routine blood tests 230 (30) 
Stays outside delivery area 108 (14)
Pregnancy-related conditions 55 (7)
Given treatment elsewhere 29 (4)
Viral load unsuppressed 22 (3)
Newly diagnosed 13 (2)
Already enrolled on CCMDD 6 (1)
Other 13 (2)
Total 757 (100)





























Home delivery accepted Home delivery rejected
HIV HIV + any NCD NCD
Fig. 4. Comparison between those who accepted and those who refused 
the service, by disease profile (N=547). (NCD = non-communicable disease).
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to others in their household when ARVs are delivered to their 
homes. This unwillingness may therefore be an indirect indication 
of the fear of stigmatisation, and of patients’ non-disclosure of their 
HIV diagnosis. Other factors affecting acceptance or otherwise of 
the home delivery option may be the patient’s age, or the perceived 
risk of COVID-19.
We believe the project has the following advantages: 
(i) Patients have the opportunity to continue life-saving medical 
treatment without risking exposure to COVID-19. 
(ii) Patients have significant cost savings in terms of transport. This 
is even more significant for those in lockdown in places further 
away from the clinic than their usual work or residences. 
(iii) The reduced use of public transport also lowers patients’ risk of 
COVID-19 infection and/or transmission. 
(iv) The opportunity cost of waiting for medication at health 
facilities may be high in the South African (SA) context. Patients 
waiting at health facilities sacrifice time that could be spent on 
more productive activities, such as employment, education or 
caregiving. Home deliveries eliminate this opportunity cost.
(v) Regular contact with the same CHW will establish continuity of 
care for patients. 
(vi) Due to the above (i - v), adherence to treatment may improve, 
with resultant improved health outcomes. This will be the 
focus of a future study.
(vii) Medication delivery may elevate the standing of CHWs in the 
health system, as they are seen to deliver tangible value to 
their clients. This is important in the context of SA’s progress 
towards universal health coverage and the important role of 
community-based PHC played by CHWs.
(viii) Health workers can manage patients without face-to-face 
contact if telehealth is used. This lowers their risk of infections 
such as COVID-19 and TB.
(ix) Implementing this approach on a large scale will mean less 
congestion at health facilities. This will alleviate the physical 
workload on scarce human resources for healthcare.
(x) Home delivery of medication can be integrated into the 
solution set that CCMDD offers. Currently, some CCMDD 
pick-up points are at the facilities themselves (Fastlane pickups). 
For these patients, the home delivery mechanism would be an 
improvement for the patient and the facility. 
(xi) Home delivery can also complement CCMDD where CHWs 
deliver medicine to patients in areas where CCMDD has no 
coverage, or to patients who have opted not to use CCMDD, 
or who do not qualify for CCMDD for non-clinical reasons.
In Table 4, we list some of the risks and mitigation strategies for 
the project. Not all of the listed risks have occurred as yet, but they 
remain on the teams’ radar in case they do.
Conclusion
We believe that this study has shown the potential for home 
delivery of chronic medication as an option for those patients 
who could not use CCMDD or were not enrolled on CCMDD at 
the start of lockdown, or as an additional stream to CCMDD. There 
is an opportunity to expand the option of home delivery of 
medications to all PHC clinics and CHCs in Tshwane, starting with 
those with the highest headcounts and the highest numbers of 
missed appointments. This will assist in strengthening CCMDD 
enrolment and delivery through telephonic consultations and 
registering ward-based outreach team (WBOT) health posts 
as pick-up points. If up to one-third of clients are eligible for 
home delivery, this could alleviate a very substantial burden on 
the health system during a time when there are new pressures. 
This may further improve networking between Tshwane health 
facilities and non-governmental organisation partners to make 
more resources available for decongestion of facilities and tracing 
patients who missed appointments. Finally, on taking a patient-
centric view of healthcare delivery, the early feedback indicates 
that this should be a service that continues beyond the current 
COVID-19 crisis period.
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Table 4. Risk and mitigation strategies
Risk Mitigation strategy
Medication lost or stolen SOPs that detail controls in place, such 
as signatures for parcels transported and 
delivered.
Patients or designated 
relatives not found, 
leading to failed delivery
Telephonic confirmation of pending 
deliveries; return of undelivered parcels 
and follow-up tracing.
Excessive cost of 
transporting medication 
where Uber is used 
(currently ~ZAR35 per 
parcel delivered)
By scaling up to include more patients, 
costs will fall dramatically. Transportation 
costs will be funded by Uber and BMGF 
until December 2020, after which the 
costs will need to be absorbed. The 
experience in the Cape Metro has shown 
that incremental costs are less than ZAR1 
per patient package in the first 2 months, 
when the project is suitably scaled. 
Medical errors due to 
the nature of remote 
consultations 
File audit, peer review and supervision by 
family physician.
Incorrect medication 
dispensed or delivered to 
patients
Pharmacist supervision. Patients given a 
number to phone if they note any errors 
in the medication.
SOP = standard operating procedure; BMGF = Bill and Melinda Gates Foundation.
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